Novel soy germ pasta improves gastric emptying time

Novel soy germ pasta improves gastric emptying time
Pasta enriched with biologically active isoflavone aglycons significantly improves gastric emptying time in patients with type 2 diabetes, according to a pilot study published online July 8 in Diabetes Care.

(HealthDay)—Pasta enriched with biologically active isoflavone aglycons significantly improves gastric emptying time in patients with type 2 diabetes, according to a pilot study published online July 8 in Diabetes Care.

Kenneth D.R. Setchell, Ph.D., from Cincinnati Children's Hospital, and colleagues randomized 10 patients with delayed gastric emptying to consume one serving per day of soy germ pasta and conventional pasta for eight weeks, with a four-week washout. The [13C]octanoic acid breath test was used at baseline and after each period to measure gastric emptying time (t1/2). Blood glucose and insulin concentrations were determined after oral glucose load.

The researchers found that soy germ pasta significantly accelerated the t1/2 in these patients, from baseline to after treatment. This change is gastric emptying time was significantly accelerated compared to that for conventional pasta, without affecting glucose or insulin concentrations.

"These findings suggest that soy germ pasta may offer a simple dietary approach to managing diabetic gastropathy," the authors write.

Two authors disclosed to Aliveris, a manufacturer of soy germ pasta.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

In diabetes, gastric emptying remains stable over time

Aug 24, 2012

(HealthDay)—Gastric emptying of solids and liquids and gastrointestinal symptoms remain stable over time in patients with long-term type 1 and type 2 diabetes, according to a study published online Aug. ...

Buspirone improves symptoms in functional dyspepsia

Oct 29, 2012

(HealthDay)—Buspirone, a 5-hydroxytryptamine 1A receptor agonist, improves symptom severity in patients with functional dyspepsia (FD), according to a proof-of-concept study published in the November issue ...

Pramlintide improves glucose control in type 1 diabetes

Jul 25, 2012

(HealthDay) -- The addition of pramlintide, an analog of the naturally-occurring β-cell peptide amylin, before meals improves blood glucose control in patients with type 1 diabetes receiving insulin through ...

Sucralose affects response to oral glucose load in obese

Jul 02, 2013

(HealthDay)—For obese adults who do not use non-nutritive sweetener (NNS), sucralose affects the glycemic and insulin responses to an oral glucose load, according to a study published online April 30 in ...

Recommended for you

Team shows why wound healing is impaired in diabetics

9 hours ago

One of the most troubling complications of diabetes is its effect on wound healing. Roughly 15 percent of diabetics will suffer from a non-healing wound in their lifetime. In some cases, these open ulcers on the skin lead ...

Progress in diabetes drug delivery

Jan 22, 2015

A drug therapy for diabetes treatment is being developed by an international research team led by WA scientists, which combines an existing anti-diabetic drug with bile acids to improve the drug's delivery ...

Roux-en-Y surgery can reverse insulin treatment in T2DM

Jan 21, 2015

(HealthDay)—Roux-en-Y gastric bypass surgery (RYGB) strongly predicts insulin cessation after surgery in insulin-treated type 2 diabetes (I-T2D) patients, independent of weight loss, according to a study ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.